CDK4 and neoplasm: Dysregulated activation of the cyclin-dependent kinases CDK2 and CDK4 has likewise been closely linked to tumorigenesis, with recent studies [54, 55] showing that persistent CDK2 and CDK4 activation not only supports tumor cell proliferation, invasion, and metastasis but may also contribute to chemoresistance, making them important therapeutic targets.